Plain-English translation of NCT07390617 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is investigating how enfortumab vedotin affects the nerves of people being treated for urothelial carcinoma (a type of bladder cancer). Researchers will use specialized nerve tests to measure whether and how this medication impacts nerve function over time. The goal is to better understand this side effect so doctors can help patients manage it more effectively.
This medication has shown promise in treating advanced bladder cancer, but some patients experience nerve damage as a side effect. This study exists to carefully measure and understand how often this happens and how severe it can be, so doctors can better predict and manage this complication.
You likely qualify if…
You likely don't qualify if…
As a participant, you would have specialized nerve function tests performed while you receive your bladder cancer treatment with enfortumab vedotin. These tests measure how well your nerves are working and would happen at different time points during your treatment. You would also complete study questionnaires about any symptoms you experience. The study involves about 50 participants total across the research center.
AI-generated summary from trial data · Jun 7, 2026 · Not medical advice
United States